Literature DB >> 2948541

Carriage rates of enterococci in the dental plaque of haemodialysis patients in Dublin.

C J Smyth, M K Halpenny, S J Ballagh.   

Abstract

The incidence of carriage of enterococci in dental plaque was determined in haemodialysis patients attending three clinics in the Dublin area either as outpatients or as hospitalised patients. Their carriage rates were compared with a University group comprising normal healthy students, academic staff, technicians and ancillary personnel and with a cohort of otherwise healthy toothache patients. The carriage rates among the staffs of the dialysis units also were examined. The overall carriage rates of enterococci of the University group, the toothache patient group, the haemodialysis patients and the dialysis unit staffs did not differ significantly from each other, ranging from 5%-20%. However, the dental plaque of a mainly hospitalised group of haemodialysis patients and their attendant staff at one clinic was colonised to a statistically significant higher degree with enterococci than that of the haemodialysis patients and the staff at the outpatient clinics, both separately and as combined patient and staff groups. Age, sex, a history of recent antibiotic therapy, and elapsed time since the last dental visit did not affect isolation rates to a significant extent. The commonest enterococcus isolated from subjects was Streptococcus faecalis, followed by its variety liquefaciens. Only one subject harboured Streptococcus durans in dental plaque. Ten of the 21 subjects yielding enterococci harboured two different enterococci in their plaque. The isolation of S. faecalis var liquefaciens alone or in combination with S. faecalis did not correlate with subject-history parameters. The findings obtained imply that antibiotic prophylaxis specifically against enterococci may be necessary only for a small number of haemodialysis patients in whom oral carriage of enterococci has been demonstrated bacteriologically.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2948541     DOI: 10.1016/0266-4356(87)90153-7

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  7 in total

Review 1.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

2.  Chronic administration of Tat-GluR23Y ameliorates cognitive dysfunction targeting CREB signaling in rats with amyloid beta neurotoxicity.

Authors:  Fatemeh Ashourpour; Adele Jafari; Parvin Babaei
Journal:  Metab Brain Dis       Date:  2021-01-09       Impact factor: 3.584

3.  Humoral immunity to commensal oral bacteria in human infants: salivary secretory immunoglobulin A antibodies reactive with Streptococcus mitis biovar 1, Streptococcus oralis, Streptococcus mutans, and Enterococcus faecalis during the first two years of life.

Authors:  M F Cole; S Bryan; M K Evans; C L Pearce; M J Sheridan; P A Sura; R L Wientzen; G H Bowden
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 4.  The epidemiology of enterococci.

Authors:  C Chenoweth; D Schaberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

Review 5.  [Rapid-acting antidepressants-neurobiological mechanisms of action].

Authors:  Peter Gass; Andrei N Vasilescu; Dragos Inta
Journal:  Nervenarzt       Date:  2021-11-11       Impact factor: 1.214

6.  Occurrence, population structure, and antimicrobial resistance of enterococci in marginal and apical periodontitis.

Authors:  Jinglu Sun; Xiaobo Song; Bjørn Erik Kristiansen; Anne Kjaereng; Rob J L Willems; Harald M Eriksen; Arnfinn Sundsfjord; Johanna E Sollid
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

7.  Bactericidal activity of erbium, chromium:yttrium-scandium-gallium-garnet laser in root canals.

Authors:  Josep Arnabat; Cesar Escribano; Anna Fenosa; Teresa Vinuesa; Cosme Gay-Escoda; Leonardo Berini; Miguel Viñas
Journal:  Lasers Med Sci       Date:  2009-06-23       Impact factor: 3.161

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.